Sofosbuvir impurity M

• CAT Number: I013101
• CAS Number: 2095551-10-1
• Molecular Formula: C₂₂H₃₀N₃O₁₀P
• Molecular Weight: 527.46
• Purity: ≥95%
• Target: HCV
• Solubility: DMSO
• IUPAC Name: propan-2-yl (2S)-2-[[[(2R,3R,4S,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
• InChI: InChI=1S/C22H30N3O10P/c1-13(2)33-19(28)14(3)24-36(31,35-15-8-6-5-7-9-15)32-12-16-18(27)22(4,30)20(34-16)25-11-10-17(26)23-21(25)29/h5-11,13-14,16,18,20,27,30H,12H2,1-4H3,(H,24,31)(H,23,26,29)/t14-,16+,18+,20+,22-,36?/m0/s1
• InChIKey: WAKQLZVLNOKKHE-YMGVOGLASA-N
• SMILES: C[C@@H](C(=O)OC(C)C)NP(=O)(OC[C@@H]1[C@H]([C@]([C@@H](O1)N2C=CC(=O)NC2=O)(C)O)O)OC3=CC=CC=C3

Sofosbuvir Impurity M（Cat No.:I013101）is a critical reference standard in the analysis and quality control of sofosbuvir, an antiviral medication used to treat hepatitis C. This impurity is studied to ensure the purity, safety, and efficacy of sofosbuvir formulations. It plays a key role in understanding degradation pathways, stability profiles, and manufacturing consistency. Sofosbuvir Impurity M is essential in regulatory compliance and in the development of robust analytical methods for impurity profiling, contributing to advancements in pharmaceutical research and the production of high-quality antiviral therapies.